Accelerating antibody development: sequence and structure-based models for predicting developability properties via size exclusion chromatography
Experimental screening for biopharmaceutical developability properties typically relies on resource-intensive, and time-consuming assays such as size exclusion chromatography (SEC). This study highlights the potential of in silico models to accelerate the screening process by exploring sequence and...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Taylor & Francis Group
2025-12-01
|
| Reeks: | mAbs |
| Onderwerpen: | |
| Online toegang: | https://www.tandfonline.com/doi/10.1080/19420862.2025.2562997 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
